Commercial Packaging

Packaging Options

Huayi’s packing lines are FMD compliant and enable clinical, commercial and stability blister and pot packing. We can help customise blister packaging to your exact specifications with image and character registration as well as perforations.

Clinical, commercial and stability packaging


Alu/Alu (including cold form)

Bottle filling and labelling

Tamper-evident sealing

2D matrix serialisation

Why become our partner?

Since our establishment, we have completed site transfers of over 50 products and supply a billion doses a year to European customers. We have successfully developed dossiers for Europe resulting in granted marketing authorisations.

We have recently expanded our capability to develop products to Chinese standards also and can produce dossiers that meet both European and Chinese requirements. Together with our associated company Velocyte, we can also offer bio-equivalence studies in China to seamlessly complete the clinical part of the development.

Huayi is committed to upgrading and developing our services. We aim to increase our current manufacturing capacity from 3 billion units to 5 billion units to satisfy demand. We have built new facilities for high-potency and oral liquids manufacturing and put in to use in 2021.

Partner with us
common 02 Created with Sketch.

API characterisation

common 02 Created with Sketch.

Analytical method development

common 02 Created with Sketch.

Formulation development

common 02 Created with Sketch.

Scale up

common 02 Created with Sketch.


common 02 Created with Sketch.

Bio-equivalence studies in China through our partner company

common 02 Created with Sketch.

Contract manufacturing and commercial supply

common 02 Created with Sketch.

Full regulatory compliance (toxicological assessment, serialisation etc.)

Research & Development

We are experienced in technology transfers and scale-up process for commercial production. Having transferred over 50 products for our customers and registering almost 100 strengths to date, we are prepared to take on new challenges in pharmaceutical development with our experienced team from Huayi China-Europe Pharmaceutical Research Institute.

Read More

01 / 04

Quality Management

Huayi’s QA team is committed to ensuring your project adheres to EU cGMP standards at every step of production from development to commercial manufacture. We will work hard to ensure that your project will be completed on time to the highest quality and stay focused and communicative throughout the process.

Read More

02 / 04

Contract Manufacturing

In 2018, our contract manufacturing output reached 1.6 billion units. Huayi manufactures solid oral dosage forms including film-coated, sugar-coated, enteric-coated, effervescent, soluble, chewable and buccal tablets as well as capsules. Our high-potency and liquid preparation facilities will be ready in 2020.

Read More

03 / 04

Integrated Services

We offer bioequivalence studies for your next project in China. Through our partners Weida Clinical Research and Velocyte Analytical Technology, we can conduct clinical trials, biological sample testing, dissolution profiling and stability studies. We can then scale-up from the test batch to commercial production.

Read More

04 / 04